178 related articles for article (PubMed ID: 19625187)
1. Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivatives.
Lee C; Lee JM; Lee NR; Kim DE; Jeong YJ; Chong Y
Bioorg Med Chem Lett; 2009 Aug; 19(16):4538-41. PubMed ID: 19625187
[TBL] [Abstract][Full Text] [Related]
2. 2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV).
Kim MK; Yu MS; Park HR; Kim KB; Lee C; Cho SY; Kang J; Yoon H; Kim DE; Choo H; Jeong YJ; Chong Y
Eur J Med Chem; 2011 Nov; 46(11):5698-704. PubMed ID: 21925774
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiviral evaluation of 7-O-arylmethylquercetin derivatives against SARS-associated coronavirus (SCV) and hepatitis C virus (HCV).
Park HR; Yoon H; Kim MK; Lee SD; Chong Y
Arch Pharm Res; 2012 Jan; 35(1):77-85. PubMed ID: 22297745
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of SARS coronavirus helicase by bismuth complexes.
Yang N; Tanner JA; Wang Z; Huang JD; Zheng BJ; Zhu N; Sun H
Chem Commun (Camb); 2007 Nov; (42):4413-5. PubMed ID: 17957304
[TBL] [Abstract][Full Text] [Related]
5. 2-Arylmethylaminomethyl-5,6-dihydroxychromone derivatives with selective anti-HCV activity.
Park HR; Park KS; Chong Y
Bioorg Med Chem Lett; 2011 Jun; 21(11):3202-5. PubMed ID: 21543225
[TBL] [Abstract][Full Text] [Related]
6. Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase/helicase.
Lee C; Lee JM; Lee NR; Jin BS; Jang KJ; Kim DE; Jeong YJ; Chong Y
Bioorg Med Chem Lett; 2009 Mar; 19(6):1636-8. PubMed ID: 19233643
[TBL] [Abstract][Full Text] [Related]
7. The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus.
Tanner JA; Zheng BJ; Zhou J; Watt RM; Jiang JQ; Wong KL; Lin YP; Lu LY; He ML; Kung HF; Kesel AJ; Huang JD
Chem Biol; 2005 Mar; 12(3):303-11. PubMed ID: 15797214
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Novel Small Molecule Inhibitor Against SARS Coronavirus Helicase.
Cho JB; Lee JM; Ahn HC; Jeong YJ
J Microbiol Biotechnol; 2015 Dec; 25(12):2007-10. PubMed ID: 26387819
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and antiviral activity of 2-(3-amino-4-piperazinylphenyl)chromone derivatives.
Kim MK; Yoon H; Barnard DL; Chong Y
Chem Pharm Bull (Tokyo); 2013; 61(4):486-8. PubMed ID: 23546009
[TBL] [Abstract][Full Text] [Related]
10. Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target.
Keum YS; Jeong YJ
Biochem Pharmacol; 2012 Nov; 84(10):1351-8. PubMed ID: 22935448
[TBL] [Abstract][Full Text] [Related]
11. The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicases.
Tanner JA; Watt RM; Chai YB; Lu LY; Lin MC; Peiris JS; Poon LL; Kung HF; Huang JD
J Biol Chem; 2003 Oct; 278(41):39578-82. PubMed ID: 12917423
[TBL] [Abstract][Full Text] [Related]
12. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
Yu MS; Lee J; Lee JM; Kim Y; Chin YW; Jee JG; Keum YS; Jeong YJ
Bioorg Med Chem Lett; 2012 Jun; 22(12):4049-54. PubMed ID: 22578462
[TBL] [Abstract][Full Text] [Related]
13. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.
Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG
Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase.
Shum KT; Tanner JA
Chembiochem; 2008 Dec; 9(18):3037-45. PubMed ID: 19031435
[TBL] [Abstract][Full Text] [Related]
15. A Novel Chemical Compound for Inhibition of SARS Coronavirus Helicase.
Lee JM; Cho JB; Ahn HC; Jung W; Jeong YJ
J Microbiol Biotechnol; 2017 Nov; 27(11):2070-2073. PubMed ID: 28910865
[TBL] [Abstract][Full Text] [Related]
16. The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling.
Pitsillou E; Liang J; Hung A; Karagiannis TC
J Mol Graph Model; 2022 Jul; 114():108193. PubMed ID: 35462185
[TBL] [Abstract][Full Text] [Related]
17. Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase.
Ivanov KA; Thiel V; Dobbe JC; van der Meer Y; Snijder EJ; Ziebuhr J
J Virol; 2004 Jun; 78(11):5619-32. PubMed ID: 15140959
[TBL] [Abstract][Full Text] [Related]
18. Determination of the functions of the putative metal-binding domain of the SCV helicase.
Huang JD; Sun HZ; Tanner JA; Watt RM
Hong Kong Med J; 2009 Oct; 15 Suppl 6():15-6. PubMed ID: 19801711
[No Abstract] [Full Text] [Related]
19. Inhibition of SARS-CoV 3CL protease by flavonoids.
Jo S; Kim S; Shin DH; Kim MS
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):145-151. PubMed ID: 31724441
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors.
Zaher NH; Mostafa MI; Altaher AY
Acta Pharm; 2020 Jun; 70(2):145-159. PubMed ID: 31955138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
